Booth number A5093


Customized biopharmaceutical facilities for aseptic process solutions.

About us

The ZETA Group, with 900 highly qualified employees and 14 subsidiaries worldwide, specializes in planning, automation, digitization and maintenance of customized biopharmaceutical facilities for aseptic process solutions. ZETA acts as a one-stop shop, combining plant engineering with HVAC and cleanroom design.

Biopharmaceutical active ingredients, such as anti-cancer drugs, insulin, vaccines and infusions are produced in these highly complex, "tailor-made" facilities. ZETA supports its customers along the entire drug development and manufacturing pathway with sophisticated solutions from laboratory to industrial production scale. Through its Smart Engineering Services, ZETA creates digital twins of process plants and has thus established itself as a market leader for digital solutions in the pharmaceutical and biotech industry.

Muenchner Str. 8
85354 Freising

Phone: +49 8161 965-6000
Internet: www.zeta.com

Contact person

Nikolay Radchenko
ZETA, OOO - Head of Development
Prospekt Mira, 104, Bld. 2, Office 128
129626 Moscow

Phone: +7 495 7213941
Internet: www.zeta.com

Products and Services


  • Bioreactors & Fermentation Systems
  • Downstream Systems
  • Preparation Systems
  • Clean Media Systems
  • CIP/SIP Systems
  • Magnetic Agitators
  • Freeze & Thaw Systems
  • FreezeContainer


  • Automation
  • kLa Measuring
  • Electropolish
  • Engineering
  • Process Optimisation & Production Design
  • Digitalization
  • Fabrication & Assembly
  • On-Site Installation
  • HVAC & Cleanroom Design
  • Qualification
  • Maintenance & Improvement
  • Supply Chain Management

ZETA Bioreactors & Fermentation Systems

At ZETA, we design customised bioreactors and
fermentation systems for production of active
ingredients from cell, yeast and bacterial cultures. The
process methodology may be batch, fed batch or

Further reading

ZETA Engineering

Engineering at the highest level is ensured by ZETA experts’ years of practical know-how and includes the following services:
Customised solutions in challenging markets
In-house know-how
laboratory testing/workshops/
mechanistic understanding of processes
Flexibility (scope of design phase)/dynamic design process as a shared development path
Combination of pilot and product tests, plant with multiple products at different volumes.

Further reading

News & Innovations

HVAC and Cleanroom Design: ZETA is expanding its service portfolio
Acting as a one-stop-shop for its customers in the pharmaceutical and biotechnology industries and meeting all their requirements is a top priority for ZETA GmbH. The Austrian company is now expanding its service portfolio with new services and a new team of fifteen HVAC and cleanroom design experts.
High quality and safety standards are key criteria in the planning and development of production facilities for the pharmaceutical and biotech companies. The building services engineering aspects are no less important, however, and demands in this field have been increasing steadily over the past few years. HVAC (heating, ventilation and air conditioning) is a central factor in this context and is subject to strict regulations, in particular in cleanrooms.
Cleanrooms in pharmaceutical and biotechnological production processes are designed with a view to minimizing the airborne particles that are either introduced into the room or generated there. Simultaneously the precise number of these particles and also the germ count are closely monitored, because any deviations can have a negative impact on production. Meeting these exacting standards requires powerful and precise HVAC systems that create optimum conditions for largely particle- and germ-free cleanrooms. Further reading

Click here if you notice an image that violates copyright or privacy rights.

Get in contact

We only use functionally necessary cookies and the web analysis tool Matomo in order to optimally design and continuously improve our website for you. By continuing to use our website, you agree to this. Further information and an objection possibility can be found here: Data protection